Proflavanol C 100
USANA

Proflavanol C 100

C+
N+ Score76
Vitamins & MineralsServing: 2 Tablet(s)Type: Botanical with Nutrients

Proflavanol C 100 is a botanical with nutrients supplement, featuring 600 mg of Vitamin C and 200 mg of Grape seed extract per 2-tablet serving. Research suggests Vitamin C may support immune function and antioxidant processes, and in this product, it is provided at a clinically studied dose. Grape seed extract is commonly used for its antioxidant properties. The product achieved an N+ Score of 76, resulting in a C+ grade, signifying a good quality supplement. With only 2 ingredients and 100% label transparency, it may be suitable for those seeking combined antioxidant support from Vitamin C and grape seed extract.

About This Product

Proflavanol C 100 by USANA is a vitamins & minerals supplement containing 2 active ingredients. It has earned an N+ Score of 76/100 (Grade C+).

This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.

Notable clinical-dose ingredients include Vitamin C.

N+ Score Breakdown

Ingredient Adequacy100/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness50/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity42/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Key ingredients at clinically effective doses
  • +Fully transparent label with individual ingredient amounts disclosed
  • +1 ingredient(s) at clinical dose levels

Weaknesses

  • No major weaknesses identified

Ingredient Analysis (2 ingredients)

IngredientAmountDose Adequacy
Vitamin C600.000 mgOptimal
Grape seed extract200.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.